SPX LABS • BATCH ANALYTICAL REPORT
GHK-Cu — 50mg
Independent Third-Party Analytical Results
PRODUCT DETAILS
Product:
GHK-Cu
SPX Label Strength:
50 mg
SPX Batch Number:
SPX-GHK50-001
ANALYTICAL INFORMATION
Analysis Date:
16 April 2026
Independent Laboratory:
Janoshik Analytical
Source Laboratory Task:
#133902
RESULTS SUMMARY
Analytical Results
| Reported Parameter | Laboratory Result | SPX Release Specification | Status |
|---|---|---|---|
| Analyte | GHK-Cu | Stated compound reported | PASS |
| Peptide Content | 50 mg | 90–120% of 50 mg label claim | PASS |
| Purity | 99.021% | ≥98.0% | PASS |
✓
PASS
BATCH ACCEPTED AGAINST SPX INTERNAL RESEARCH-MATERIAL RELEASE CRITERIA
SPX INTERNAL RELEASE SPECIFICATION
For research-material release, SPX Labs uses confirmation that the stated analyte is reported in the supporting laboratory documentation, a peptide-purity acceptance criterion of ≥98.0%, and a provisional peptide-content acceptance range of 90–120% of the stated SPX label claim.
These are SPX Labs internal commercial research-material acceptance criteria. They are not represented as pharmacopoeial, regulatory or universal peptide-industry standards.
Verify This Batch
SPX batch reference: SPX-GHK50-001
This is the official SPX Labs public batch record associated with batch SPX-GHK50-001. The analytical information displayed on this page corresponds to supporting independent third-party laboratory documentation retained within the SPX Labs batch record.
IMPORTANT REPORT INFORMATION
This page is an SPX Labs customer-facing analytical summary derived from independent third-party laboratory documentation associated with the referenced batch. SPX Labs did not perform the underlying analytical testing.
The laboratory reported GHK-Cu at 50 mg with a reported purity of 99.021%. No analytical method is stated on this SPX summary unless explicitly supported by the underlying laboratory report.
Reported analytical values are reproduced from the supporting laboratory documentation. The original third-party report is retained within SPX Labs internal batch records.
The analytical results apply to the laboratory sample represented by the supporting report and should not be interpreted as independent analytical testing of every individual vial within the batch.
Only analytical characteristics explicitly reported in the supporting laboratory documentation are represented as tested. No additional quality characteristic should be inferred from this page.
The PASS designation refers only to the SPX Labs internal research-material acceptance criteria displayed above and does not constitute medicinal, pharmaceutical, clinical or regulatory approval.
This analytical summary is provided solely for research-material quality documentation and does not constitute a medical, therapeutic, diagnostic or suitability-for-human-use claim.
Research Use Only
SPX Labs products are supplied exclusively for legitimate laboratory research, analytical testing and scientific evaluation. Products are not supplied for human or veterinary use and are not intended to diagnose, treat, cure or prevent disease.